Role of A-Kinase Anchoring Protein 1 in Retinal Ganglion Cells: Neurodegeneration and Neuroprotection
Cells · 2023
DOI: 10.3390/cells12111539 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, 2023. Verfasst von Tonking Bastola und 7 weiteren Autor:innen. Beteiligte Einrichtung: Hamilton Glaucoma Center and Shiley Eye Institute, The Viterbi Family Department of Ophthalmology, University of California San Diego, La Jolla, CA 9…. Hauptthemen laut MEDLINE: Retinal Ganglion Cells, Glaucoma. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 111 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NEI NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
A-Kinase anchoring protein 1 (AKAP1) is a multifunctional mitochondrial scaffold protein that regulates mitochondrial dynamics, bioenergetics, and calcium homeostasis by anchoring several proteins, including protein kinase A, to the outer mitochondrial membrane. Glaucoma is a complex, multifactorial disease characterized by a slow and progressive degeneration of the optic nerve and retinal ganglion cells (RGCs), ultimately resulting in vision loss. Impairment of the mitochondrial network and function is linked to glaucomatous neurodegeneration. Loss of AKAP1 induces dynamin-related protein 1 dephosphorylation-mediated mitochondrial fragmentation and loss of RGCs. Elevated intraocular pressure triggers a significant reduction in AKAP1 protein expression in the glaucomatous retina. Amplification of AKAP1 expression protects RGCs from oxidative stress. Hence, modulation of AKAP1 could be considered a potential therapeutic target for neuroprotective intervention in glaucoma and other mitochondria-associated optic neuropathies. This review covers the current research on the role of AKAP1 in the maintenance of mitochondrial dynamics, bioenergetics, and mitophagy in RGCs and provides a scientific basis to identify and develop new therapeutic strategies that could protect RGCs and their axons in glaucoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hamilton Glaucoma Center and Shiley Eye Institute, The Viterbi Family Department of Ophthalmology, University of California San Diego, La Jolla, CA 92093, USA.
- National Center for Microscopy and Imaging Research, Department of Neurosciences, University of California San Diego, La Jolla, CA 92093, USA.
- Department of Ophthalmology and Visual Science, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.
- Department of Ophthalmology and Visual Science, St. Vincent's Hospital, Jungbu-daero 93, Paldal-gu, Suwon 16247, Republic of Korea.
- Department of Pharmacology, Iowa Neuroscience Institute, University of Iowa, Iowa City, IA 52242, USA.
ORCID-Profile: Tonking Bastola, Guy A Perkins, Ziyao Shen, Stefan Strack, Won-Kyu Ju
Förderung
- NEI NIH HHS
- National Institutes of Health
Zitieren
APA
Bastola, T., Perkins, G. A., Kim, K. Y., Choi, S., Kwon, J. W., Shen, Z., Strack, S., & Ju, W. K. (2023). Role of A-Kinase Anchoring Protein 1 in Retinal Ganglion Cells: Neurodegeneration and Neuroprotection. Cells. https://doi.org/10.3390/cells12111539
Vancouver
Bastola T, Perkins GA, Kim KY, Choi S, Kwon JW, Shen Z, et al. Role of A-Kinase Anchoring Protein 1 in Retinal Ganglion Cells: Neurodegeneration and Neuroprotection. Cells. 2023. doi:10.3390/cells12111539
BibTeX
@article{Bastola2023,
author = {Bastola, Tonking and Perkins, Guy A and Kim, Keun-Young and Choi, Seunghwan and Kwon, Jin-Woo and Shen, Ziyao and Strack, Stefan and Ju, Won-Kyu},
title = {Role of A-Kinase Anchoring Protein 1 in Retinal Ganglion Cells: Neurodegeneration and Neuroprotection},
journal = {Cells},
year = {2023},
doi = {10.3390/cells12111539}
}
EUVIMED